StudyFinder

Alport Syndrome Treatments and Outcomes Registry

Recruiting

The Alport Syndrome Treatments and Outcomes Registry (ASTOR) was founded in 2007 with the goal of facilitating clinical trials of new treatments for the disease. Because Alport syndrome is a rare disorder, rapid recruitment of sufficient participants for meaningful therapeutic trials will be greatly enhanced by pre-existing patient registries.

I'm interested

All
up to 99 Years old
This study is NOT accepting healthy volunteers
Inclusion Criteria:
History of a diagnosis of Alport syndrome, Family or individuals need to be able to comprehend the consent and HIPAA forms written in the English language.
Exclusion Criteria:
Uncertain diagnosis of Alport syndrome.

Alport Syndrome

Alport Syndrome, x linked, autosomal dominant Alport syndrome, glomerular basement membrane, hereditary nephritis, familial benign haematuria, type IV collagen, hereditary nephritis with neurosensory deafness, vison loss

Sarah Lemmage - lemmage@umn.edu
N/A
NCT00481130
See this study on ClinicalTrials.gov

Back